Trade unions and the Swiss Bank Employees Association (SBEA) want clarity, particularly for Credit Suisse’s 16,000 Swiss workers.
They have demanded the establishment of a special taskforce to ease the pain of redundancies and to help people aged over-55 to find new employment.
The SBEA pointed out that Credit Suisse indirectly supports other jobs, such as building maintenance and catering professionals.
“In addition, tens of thousands of jobs outside of the banking industry would potentially be at risk,” the organisation stated.
The Swiss financial sector supports 230,600 full time posts, which is 5.5% of the total Swiss workforce. Banks directly employ some 150,500 of these workers.
UBS and Credit Suisse employ 1,700 people in Geneva, making up 10% of all bank jobs in the city.
Further afield, both big banks employ thousands of other staff around the world from Europe to Asia and the Americas.
Large financial centres such as London and New York are bracing themselves for a spate of redundancies.
In a conference call with analysts on Sunday, UBS CEO Ralph Hamers said the enlarged bank has targeted $8 billion (CHF7.4 billion) in cost savings by 2027. Around $6 billion of these savings will likely come from staff reductions, reports the Financial Times.
Related Stories
Popular Stories
More
International Geneva
A Geneva-based global health foundation came close to ‘collapse’. Where were regulators?
Swiss Senate wants to boost higher vocational training
This content was published on
The Swiss Senate has adopted a government proposal to improve the attractiveness of higher vocational education and training
Man who drove into Swiss pro-Palestine demo released
This content was published on
The motorist who forced his way through a pro-Palestinian demonstration in Lausanne on Saturday was released on Monday. He had not acted for political or ideological reasons.
German financial fraudster sent to prison by Swiss court
This content was published on
The financier Florian Homm has been sentenced to six years and seven months in prison without probation. He was found guilty of commercial fraud, serious money laundering and forgery of documents.
This content was published on
Swiss pharmaceutical company Novartis is buying in the United States. The biopharmaceutical company Tourmaline Bio is to be acquired for around $1.4 billion (CHF1.1 billion).
Swiss Senate rejects sanctions against Israeli settlers
This content was published on
The Swiss Senate has rejected a call for Switzerland to join the EU’s sanctions against violent Israeli settlers. The majority also did not want an end to military cooperation with Israel.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.